Impact of dabigatran on a large panel of routine or specific coagulation assays
Top Cited Papers
- 1 January 2012
- journal article
- research article
- Published by Georg Thieme Verlag KG in Thrombosis and Haemostasis
- Vol. 107 (05), 985-997
- https://doi.org/10.1160/th11-11-0804
Abstract
Schattauer GmbH - Verlag für Medizin und Naturwissenschaften ist ein renommierter Herausgeber von Fachbüchern, -zeitschriften und -software. Besuchen Sie unser Internetangebot mit Onlinezugang zu unseren ZeitschriftenartikelnKeywords
This publication has 37 references indexed in Scilit:
- Reversal of Rivaroxaban and Dabigatran by Prothrombin Complex ConcentrateCell Metabolism, 2011
- Bleeding risk and reversal strategies for old and new anticoagulants and antiplatelet agentsJournal of Thrombosis and Haemostasis, 2011
- Drug and dietary interactions of warfarin and novel oral anticoagulants: an updateJournal of Thrombosis and Thrombolysis, 2011
- Comparative efficacy and safety of the novel oral anticoagulants dabigatran, rivaroxaban and apixaban in preclinical and clinical developmentThrombosis and Haemostasis, 2010
- Dabigatran etexilate – a novel, reversible, oral direct thrombin inhibitor: Interpretation of coagulation assays and reversal of anticoagulant activityThrombosis and Haemostasis, 2010
- Efficacy and safety of dabigatran etexilate for the prevention of venous thromboembolism following total hip or knee arthroplastyThrombosis and Haemostasis, 2009
- Dabigatran Etexilate: An Oral Direct Thrombin Inhibitor for Prophylaxis and Treatment of Thromboembolic DiseasesPharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 2008
- Pharmacokinetics and Pharmacodynamics of the Direct Oral Thrombin Inhibitor Dabigatran in Healthy Elderly SubjectsClinical Pharmacokinetics, 2008
- Clinical Pharmacokinetics and Pharmacodynamics of the Oral Direct Thrombin??Inhibitor Dabigatran EtexilateClinical Pharmacokinetics, 2008
- The Pharmacology and Management of the Vitamin K AntagonistsChest, 2004